Visipaque Injection, Solution
Product Images NDC 0407-2223

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Visipaque (NDC 0407-2223). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ge Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Visipaque 01)

Chemical structure of Visipaque (iodixanol) showing the molecular arrangement of iodine atoms, hydroxyl groups, and amide linkages in the compound.*

FDA Label Image

Principal Display Panel (320 mgI/mL Bottle Label)

Visipaque 320 mg/mL (iodixanol) Injection label for a multi-dose bottle package containing 10 x 500 mL bottles. The label states 'PHARMACY BULK PACKAGE Not for Direct Infusion' and 'NOT FOR INTRATHECAL USE,' indicating it is a sterile aqueous injection in a PlusPak polymer bottle. The product is distributed by GE Healthcare Inc.*

FDA Label Image

Principal Display Panel (270 mgI/mL Bottle Label)

Visipaque 270 mg/mL (iodixanol) Injection label from GE Healthcare Inc. This packaging label is for a 500 mL multi-dose sterile aqueous injection in a PlusPak polymer bottle. The label includes warnings such as not for intrathecal use and instructions about tamper-evident seals, along with barcodes and detailed product information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.